Omega-3 Market: Innovations Shaping Consumer Preferences

The omega-3 market is estimated to be USD 4,362.2 million in 2025 and is projected to reach USD 7,756.4 million by 2030, at a CAGR of 12.2% from 2025 to 2030. Demand for omega-3 is projected to grow significantly as consumers become more aware of its role in supporting cardiovascular, cognitive, eye, and joint health. Unlike several other nutrients, omega-3 fatty acids, such as EPA and DHA, cannot be synthesized efficiently by the human body, resulting in increased reliance on dietary supplements, fortified foods, and pharmaceutical-grade formulations. Omega-3 oils are highly versatile and can be incorporated into capsules, powders, beverages, and functional foods while maintaining stability and efficacy. Fish oil, krill oil, and algal-based omega-3 are the most preferred sources, backed by scientific validation of their safety and effectiveness. The growing popularity among health-conscious consumers, coupled with increasing demand for clean-label and sustainable products, is expected to further strengthen the outlook for the omega-3 market in the coming years.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227

By type, DHA segment to exhibit fastest growth rate during forecast period.

Docosahexaenoic acid (DHA), a polyunsaturated omega-3 fatty acid (PUFA), is widely distributed throughout the body and has emerged as the leading type segment in the omega-3 market. It serves as a significant structural fat present in both the brain and eye, constituting as much as 97% of the total omega-3 fats in the brain and up to 93% in the retina. The main sources of DHA are fish, fish oils, dairy products, and specialty eggs, with marine sources such as salmon and tuna being particularly rich. Farmed salmon contains about 1.24 g of DHA, and wild salmon about 1.22 g of DHA.

Additionally, DHA is a crucial component of cardiac tissue and is also commonly referred to as 22:6(n-3). Direct consumption of DHA is necessary to effectively increase fatty acid levels in the body, and optimal intake is crucial for both infant brain development and normal adult brain function. Epidemiological research further associates healthy DHA intake with a reduced risk of Alzheimer’s disease, as DHA improves communication between nerve cells and membranes by enhancing fluidity. Its critical role in visual and neurological development in infants, coupled with widespread applications in infant nutrition, dietary supplements, and functional foods, has solidified DHA as the dominating segment within the omega-3 market. The growing demand from both developed and emerging economies ensures that DHA continues to hold a substantial market share compared to other omega-3 types, such as EPA and ALA.

By application, infant formulas segment to record highest CAGR during forecast period.

The infant formulas segment is anticipated to grow at a significant rate in the omega-3 market due to the rising recognition of DHA’s crucial role in infant brain and eye development. DHA, often referred to as the “brain-building” omega-3, is recommended by leading health authorities such as the World Health Organization (WHO) and the European Food Safety Authority (EFSA) for inclusion in infant nutrition. With an increasing number of working mothers and a higher reliance on formula feeding, demand for fortified infant formulas containing DHA and EPA has surged worldwide. Manufacturers are consistently innovating by introducing premium formulas that mimic the fatty acid composition of human breast milk, further boosting adoption. Regulatory mandates in many regions, such as the EU’s requirement since 2020 for DHA inclusion in all infant formula and follow-on formula products, have led to the European Union (EU) implementing new regulations, effective February 22, 2021, regarding the recommended DHA supplementation in healthy diets. These regulations mandate that all infant formula and follow-on formula available for purchase within the EU must contain a minimum of 20 mg/100 kcal (or 4.8 mg/100 kJ) and a maximum of 50 mg/100 kcal (or 128 mg/100 kJ) of DHA, which is accelerating market growth. In addition, growing consumer preference for organic and clean-label formulas, along with strong demand in emerging economies driven by rising birth rates and improved purchasing power, is expected to fuel the segment's expansion during the forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=227

Europe to account for significant share in global omega-3 market.

Europe is expected to hold a significant share of the omega-3 market, driven by a robust regulatory framework, high consumer awareness, and a growing preference for preventive healthcare. Additionally, European consumers show a higher inclination toward premium dietary supplements and clean-label products, fostering demand for sustainable fish oil and plant/algal-based omega-3 alternatives. The presence of major global players, continuous research and development initiatives, and widespread adoption of fortified foods and beverages further strengthen Europe’s dominance. Moreover, increasing vegetarian and flexitarian populations in countries such as Germany, the UK, and France are accelerating the demand for algal-derived omega-3, ensuring steady market growth across the region. According to the European Food Safety Authority (EFSA), micronutrients present in omega-3s even benefit eye and brain health, which has led to heavy focus and a surge in consumption among Europeans. Companies such as Pelagia AS (Norway), Corbion (Netherlands), and dsm-firmenich (Netherlands) are the key players that are highly focused on catering to the demand for omega-3-based products in the European region. In 2023, several recent advancements were observed in the omega-3 market within the European region. Corbion (Netherlands) launched a new product, AlgaVia, whereas Pelagia AS (Norway) invested in its production facility to increase the output of the omega-3 concentrates.

The European Society of Cardiology (ESC) has had a significant impact on the omega-3 market in the European region, as its studies emphasize that omega-3 consumption helps decrease the risk of cardiovascular diseases. European omega-3 manufacturers are investing in omega-3 applications, such as dietary supplements, functional food & beverages, and pharmaceuticals. BASF SE (Germany) offers microencapsulated omega-3 powder with more shelf life to cater to the European demand. Furthermore, the rise in consumer awareness has prompted manufacturers to follow and adhere to European regulations, which is projected to drive growth in Europe.

Leading Omega-3 Manufacturers:

The report profiles key players such as BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International plc (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), AlgaeCytes Limited (UK), and others.

Food Enzymes Market Size, Share, and Competitive Landscape - 2030

The food enzymes market is estimated to be USD 2.98 billion in 2025 and is projected to reach USD 4.20 billion by 2030, at a CAGR of 7.2% from 2025 to 2030. The food enzymes market is witnessing robust growth as food and beverage manufacturers increasingly adopt enzyme-based solutions to improve processing efficiency, enhance product quality, and meet the evolving demands of health-conscious consumers. With applications ranging from dairy, bakery, and beverages to convenience foods and functional nutrition, food enzymes play a vital role in enhancing flavor, texture, shelf life, and digestibility. This surge in demand is being further fueled by advancements in biotechnology, clean-label trends, and regulatory support for sustainable and innovative food production processes, positioning the food enzymes market as a key driver in the future of food innovation.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=800

By source, microorganisms segment accounts for largest market share

Microorganisms represent the dominant segment in the global food enzymes market, driven by their efficiency, cost-effectiveness, and scalability in industrial applications. Enzymes derived from microbial sources such as bacteria, fungi, and yeasts are widely preferred due to their consistent performance, ease of production through fermentation, and adaptability across diverse food processing functions. Compared to plant or animal-derived enzymes, microbial enzymes offer more stability under varying temperature and pH conditions, making them suitable for high-demand processes in the bakery, dairy, beverages, and meat industries. Advances in biotechnology and genetic engineering have further enhanced the functionality of microbial enzymes, enabling tailored solutions that improve food quality, extend shelf life, and support clean-label product trends. Additionally, the growing shift toward sustainable and plant-based diets has amplified demand for microbial enzymes, as they align with consumer expectations for natural, non-animal-based ingredients. With continuous R&D investments and regulatory approvals supporting novel enzyme applications, microorganisms are expected to retain their leading position, underpinning growth and innovation in the food enzymes sector.

By type, lipases segment accounts for significant market share

Lipase enzymes hold a significant position within the food enzymes market, owing to their vital role in catalyzing the hydrolysis of fats, thereby improving the flavor, texture, and nutritional profile of various food products, including dairy, baked goods, and edible oils. Their capacity to effectively convert triglycerides into valuable components such as fatty acids and glycerol also supports broader applications in industrial biotechnology, particularly in the development of sustainable and environmentally responsible solutions. On September 16, 2024, Biocatalysts Ltd. introduced Lipomod 70MDP, a next-generation lipase specifically designed for the efficient hydrolysis of plant-based oils. This cutting-edge enzyme is engineered to enhance yields and process efficiency in the oleochemical industry, offering a viable alternative to conventional chemical-based methods. The launch of Lipomod 70MDP highlights Biocatalysts' ongoing commitment to sustainable innovation and operational excellence. As enzymatic technologies continue to gain traction across food and industrial domains, lipase remains a key driver of growth, with products like Lipomod 70MDP reinforcing its strategic importance and future potential in the global food enzymes landscape.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=800

Based on region, North America accounts for significant market share

North America holds a significant share in the food enzymes market, driven by the region’s strong bakery, dairy, and beverage industries, along with rising consumer demand for clean-label and longer-lasting products. This growth is supported by continuous innovation and strategic collaborations. For instance, on August 13, 2025, IFF launched POWERFRESH ACE 2000, a next-generation fresh-keeping enzyme tailored to US industrial bakeries. The enzyme improves bread softness and resilience for up to 34 days, addressing consumer expectations for extended freshness while enhancing production efficiency. Similarly, on September 15, 2025, Brenntag Specialties expanded its exclusive partnership with Lallemand Bio-Ingredients to distribute the Nutrilife baking enzyme range in North America, building on their existing European collaboration. This partnership aims to bring clean-label, high-performance enzyme solutions to the US. and Canadian markets, backed by Brenntag’s distribution strength and Lallemand’s fermentation expertise. These strategic initiatives reflect North America’s central role in the global food enzymes market, where innovation, consumer trends, and industrial efficiency converge to drive sustained market leadership and long-term growth opportunities.

The report profiles key players such as International Flavors & Fragrances Inc. (US), dsm-firmenich (Switzerland), Kerry Group plc (Ireland), Advanced Enzyme Technologies (India), Aumgene Biosciences (India), Amano Enzyme Inc. (Japan), Associated British Foods plc (England), and Novonesis Group (Denmark).

Agricultural Biologicals Market Size, Share, and Industry Insights

The global agricultural biologicals market is valued at USD 18.44 billion in 2025 and is projected to grow to USD 34.99 billion by 2030, registering a CAGR of 13.7% during the forecast period. Advances in biotechnology and microbial research have significantly improved the efficiency and specificity of biological products, making them increasingly appealing to farmers. With growing awareness about the importance of soil health, many farmers now recognize that long-term productivity depends on maintaining soil vitality. Agricultural biologicals—such as biofertilizers and biostimulants—play a crucial role in enriching soil fertility and fostering beneficial microbial activity, which in turn enhances crop resilience and yields.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100393324

Crop Type: Fruits & Vegetables Segment Leads the Market

The fruits and vegetables segment is expected to hold the largest market share throughout the forecast period. These crops are particularly vulnerable to pests and diseases, driving the demand for sustainable, biological pest management solutions. Biological products, including beneficial microbes and natural substances, offer eco-friendly pest control with minimal chemical residues while supporting soil health. Additionally, consumer preference for organic and residue-free produce further boosts demand. Due to the high commercial value of fruits and vegetables, farmers are more willing to invest in biologicals to ensure maximum yield and quality.

Mode of Application: Seed Treatment Segment Witnesses Fastest Growth

Seed treatment is projected to register the highest CAGR during the forecast period. This method is gaining traction as a proactive approach to safeguard crop health and boost yields from the outset. Biological seed treatments protect seeds against pests, pathogens, and environmental factors, improving germination rates and seedling vigor. The increasing adoption of sustainable and organic farming practices further promotes the shift toward biological seed treatments, which reduce chemical dependency and lower environmental risks. As farmers seek cleaner and more efficient solutions, this segment is expected to expand rapidly.

Source: Natural Products Segment Holds Second-Largest Share

The natural products segment ranks second in terms of market share and comprises products derived from plants, animals, or microorganisms. These naturally sourced inputs manage pests, enhance soil fertility, and promote crop health while avoiding the side effects associated with synthetic chemicals. Growing consumer demand for residue-free and organic food has increased the use of natural products in agriculture. Their essential role in integrated pest management and sustainable soil programs underscores their significance within the agricultural biologicals market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=100393324

Regional Insights: Asia Pacific to Register Strong Growth

The Asia Pacific region is anticipated to record robust growth in the coming years, driven by its vast agricultural base, rising food demand, and increasing adoption of precision farming technologies. Countries such as China, India, and Southeast Asian nations are embracing agricultural biologicals to boost farm productivity and environmental sustainability. Government initiatives promoting eco-friendly farming, alongside growing consumer interest in organic produce, are accelerating market expansion. Enhanced awareness of soil conservation and sustainable pest management practices further supports the region’s positive market outlook.

Key Market Players:

Leading companies in the agricultural biologicals market include BASF SE (Germany), Syngenta Group (Switzerland), Bayer AG (Germany), FMC Corporation (US), Corteva (US), UPL (India), Nufarm (Australia), Novonesis (Denmark), Lallemand Inc. (Canada), Mosaic (US), Rovensa Next (Spain), Sumitomo Chemical Co., Ltd. (Japan), SEIPASA, S.A. (Spain), Koppert (Netherlands), and Gowan Company (US).